Estrogen Receptor and Signal Transducer and Activator of Transcription 3 Expression in Equine Mammary Tumors.

The research involves examining characteristics of mammary tumours in horses, particularly their expressions of estrogen receptor alpha and the transcription factor STAT3. The study’s findings suggest that some of these tumours have a malignant phenotype and may share molecular similarities with analogous tumours found in cats and dogs.

Objective of the Research

• The main objective of this research was to analyse the histopathologic features of equine mamary tumors, which are rare and not well documented. The team sought to examine the expression of various proteins in these tumors, most specifically the estrogen receptor alpha and the transcription factor STAT3.

Findings

• Through the research, the team found that the tumors investigated displayed infiltrative growth, intermediate to high mitotic rates, and focally extensive necrosis – all indicative of a malignant phenotype.
• The tumors demonstrated variably strong staining for vimentin and cytokeratin 14 as well as frequently weak cytoplasmic staining for pan-cytokeratin.
• Interestingly, the expression of E-cadherin, which is an important protein in cell-cell adhesion and is often down-regulated in cancer, was reportedly strong.
• A subgroup of the tumors demonstrated strong nuclear staining for the estrogen receptor alpha. This suggests that the tumors may respond to estrogen, a hormone known to promote cell proliferation in the presence of certain receptors.
• STAT3, a transcription factor known to drive cell survival and proliferation in several types of cancer, was also present in the nuclei of some of the tumors. This suggests it was transcriptionally active, potentially contributing to the malignancy of the tumors. It was rare to see nuclear STAT3 expression in carcinomas with moderate to intense staining for cytokeratin 14.

Implications and Conclusion

• These findings contribute new information to the sparse existing data on equine mammary tumors.
• Identifying estrogen receptor alpha expression and transcriptionally active STAT3 in a subset of these tumors suggests these equine cancers may share some molecular behavior with similar tumors in cats and dogs.
• This discovery opens up potential avenues for exploring targeted therapies that modulate the activity of these molecular actors, estrogen receptor alpha and STAT3, in the treatment of equine mammary tumors.